The Food and Drug Administration (FDA) on Friday, September 3, approved the emergency use of the Moderna COVID-19 vaccine for adolescents aged 12 to 17.
FDA Director-General Eric Domingo said in a press briefing that with the Delta variant affecting many children, the experts saw the “benefit of using the vaccine outweigh the risks.”
The approval came after the agency’s regulatory experts go-signal to use the Moderna vaccine to immunize the said age group.
In the last month of June, the FDA also approved the vaccination of children aged 12 and above with Pfizer-BioNTech Vaccine.
And on August 25, the World Health Organization (WHO) recommended the vaccination of children with comorbidity.